<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T23:52:12Z</responseDate>
  <request identifier="oai:figshare.com:article/34025350" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34025350</identifier>
        <datestamp>2026-09-29T17:16:20Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_915</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Picolinate-
and Phosphonated Pyridyl-TACN Ligands
for Highly Stable and Inert Cu(II) Complexes for Radiochemical Applications</dc:title>
          <dc:creator>Tarek El Sayed (12846491)</dc:creator>
          <dc:creator>Monika Rana (5558099)</dc:creator>
          <dc:creator>Saumitra Bhowmik (12269438)</dc:creator>
          <dc:creator>Iwona T. Dobrucki (10315936)</dc:creator>
          <dc:creator>Lawrence W. Dobrucki (1910665)</dc:creator>
          <dc:creator>Liviu M. Mirica (1341486)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Physical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>positron emission tomography</dc:subject>
          <dc:subject>partial liver excretion</dc:subject>
          <dc:subject>electron paramagnetic resonance</dc:subject>
          <dc:subject>excretion pathway due</dc:subject>
          <dc:subject>two phosphonated pyridine</dc:subject>
          <dc:subject>tacn analogue exhibited</dc:subject>
          <dc:subject>64 &lt;/ sup</dc:subject>
          <dc:subject>cu radiolabeling studies</dc:subject>
          <dc:subject>cu pet imaging</dc:subject>
          <dc:subject>ligands contain picolinate</dc:subject>
          <dc:subject>imaging studies</dc:subject>
          <dc:subject>vivo &lt;/</dc:subject>
          <dc:subject>renal pathway</dc:subject>
          <dc:subject>phosphonated pyridyl</dc:subject>
          <dc:subject>phosphonated pyridines</dc:subject>
          <dc:subject>inert cu</dc:subject>
          <dc:subject>vis spectroscopy</dc:subject>
          <dc:subject>tacn ligands</dc:subject>
          <dc:subject>solution chemistry</dc:subject>
          <dc:subject>radiochemical applications</dc:subject>
          <dc:subject>optimal five</dc:subject>
          <dc:subject>lipophilic nature</dc:subject>
          <dc:subject>ligand platform</dc:subject>
          <dc:subject>highly stable</dc:subject>
          <dc:subject>excreted via</dc:subject>
          <dc:subject>epr ),</dc:subject>
          <dc:subject>cyclic voltammetry</dc:subject>
          <dc:subject>cv ).</dc:subject>
          <dc:subject>coordinate geometry</dc:subject>
          <dc:description>In this study, three
novel chelators based on the 1,4,7-triazacyclononane
(TACN) ligand platform were introduced. The ligands contain picolinate
and phosphonated pyridine chelating arms to provide an optimal five-coordinate
geometry for Cu(II). The solution chemistry of these complexes was
systematically investigated using spectrophotometric titrations, UV-vis
spectroscopy, electron paramagnetic resonance (EPR), and cyclic voltammetry
(CV). Then, these ligands were employed in &lt;sup&gt;64&lt;/sup&gt;Cu radiolabeling
studies and subsequent &lt;i&gt;in vivo&lt;/i&gt; positron emission
tomography (PET) imaging studies to reveal that the &lt;sup&gt;64&lt;/sup&gt;Cu
complexes of the two phosphonated pyridine-TACN ligands were excreted
via the renal pathway, while the picolinate-TACN analogue exhibited
a shift in the excretion pathway due to its lipophilic nature, resulting
in partial liver excretion. To our knowledge, the use of phosphonated
pyridines as chelators in &lt;sup&gt;64&lt;/sup&gt;Cu PET imaging is uncommon,
which underscores the significance of this study.</dc:description>
          <dc:date>2026-09-29T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acs.inorgchem.6c03664.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Picolinate-_and_Phosphonated_Pyridyl-TACN_Ligands_for_Highly_Stable_and_Inert_Cu_II_Complexes_for_Radiochemical_Applications/34025350</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
